Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Class A Common Shares
-
Shares outstanding
-
98,656,192
-
Total 13F shares
-
5,264,558
-
Share change
-
-516,070
-
Total reported value
-
$8,084,489
-
Put/Call ratio
-
6.4%
-
Price per share
-
$1.54
-
Number of holders
-
22
-
Value change
-
-$1,067,974
-
Number of buys
-
11
-
Number of sells
-
13
Institutional Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) as of Q1 2022
As of 31 Mar 2022,
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,264,558 shares.
The largest 10 holders included
MMCAP International Inc. SPC, Mirae Asset Global Investments Co., Ltd., Vident Investment Advisory, LLC, TWO SIGMA ADVISERS, LP, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, ROYAL BANK OF CANADA, Marble Harbor Investment Counsel, LLC, and CITADEL ADVISORS LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.